Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Seelos Therapeutics, Inc. - Common Stock
(NQ:
SEEL
)
1.280
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seelos Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
The "Multi-Bagger" Portfolio Update: January 20th, 2023
↗
January 22, 2023
Cannabis, psychedelic and plant-based food stocks performed terribly in 2022 so one could be excused for thinking they have probably reached bottom - hence this portfolio.
Via
Talk Markets
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
↗
January 21, 2023
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different...
Via
Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 20, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
↗
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
January 18, 2023
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 18, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023
↗
January 17, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023
↗
January 11, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023
↗
January 10, 2023
Via
Benzinga
Psychedelic Drug Developer Mindset Pharma Optimistic About 2023 After Key 2022 Funding Collaborations And Patent Allowances
↗
January 18, 2023
Once considered the realm of ancient civilizations and countercultures, psychedelics have in the past few years been seeing increasing interest.
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
↗
January 16, 2023
Via
Benzinga
A "Multi-Bagger" Portfolio For 2023 - Introduction
↗
January 14, 2023
I am optimistic that the market will perform better in 2023 so I've put together a basket of 10 stocks that could well realize multi-bagger returns this year.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From January 13, 2023
↗
January 13, 2023
Via
Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
↗
January 12, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 9, 2023
↗
January 09, 2023
Via
Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today
↗
January 06, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023
↗
January 05, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
↗
January 04, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 3, 2023
↗
January 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 2, 2023
↗
January 02, 2023
Via
Benzinga
6 Largest Psychedelic Drug Stocks Were -20% In December
↗
January 02, 2023
The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 30, 2022
↗
December 30, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 29, 2022
↗
December 29, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 28, 2022
↗
December 28, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 27, 2022
↗
December 27, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 26, 2022
↗
December 26, 2022
Via
Benzinga
Largest Psychedelic Stocks -7.6% This Week; Now -21.7% This Month
↗
December 25, 2022
Highlighting the performance of the six stocks in our Psychedelic Drug Stocks Index, which are researching the treatment of mental illnesses using 10 different psychedelic substances.
Via
Talk Markets
Cannabis Category Performances Ranged From +0.5% To -17% Last Week
↗
December 25, 2022
The 5 categories in the cannabis sector perform quite differently week-to-week and last week was no exception. Below is a summary of each category's performance last week, in descending order, since...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 23, 2022
↗
December 23, 2022
Via
Benzinga
Cybin, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
December 22, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today